2023: A year of accomplishments for the 13 Science Citation Index Expanded- and Emerging Sources Citation Index-indexed Baishideng journals

被引:0
|
作者
Wang, Jin-Lei [1 ]
Yan, Jia-Ping [1 ]
Fan, Jia-Ru [1 ]
Li, Xiang [1 ]
Guo, Xu [1 ]
Li, Jia-Wei [1 ]
Wu, Yun-Xiaojian [1 ]
Wang, Jing-Jie [1 ]
Chen, Yu-Lu [1 ]
Li, Li [1 ]
Lin, Cong [1 ]
Qu, Xin-Liang [1 ]
Liu, Ji-Hong [1 ]
Zhang, Yan-Liang [1 ]
Yuan, Ying-Yi [1 ]
Yu, Hua-Ge [1 ]
Chen, Yu-Xi [1 ]
Cai, Yi-Xuan [1 ]
Zhang, Xiang-Di [1 ]
Zhao, Si [1 ]
Xu, Zi-Hang [1 ]
Ma, Li [1 ]
Ma, Na [1 ]
Guo, Diao-Mei [1 ]
Ma, Lian-Sheng [1 ,2 ]
机构
[1] Baishideng Publishing Grp Inc, Pleasanton, CA 94566 USA
[2] Baishideng Publishing Grp Inc, Pleasanton, CA 94566 USA
关键词
Baishideng Publishing Group; Journal Impact Factor; Open access; Policy changes; Policy additions; Unique advantages; Anxiety disorders; Colorectal cancer; Inflammatory bowel disease; Hepatocellular carcinoma; Gut microbes; Atrial fibrillation; DISEASE; MANAGEMENT;
D O I
10.3748/wjg.v30.i1.9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In 2023, Baishideng Publishing Group (Baishideng) routinely published 47 open-access journals, including 46 English-language journals and 1 Chinese-language journal. Our successes were accomplished through the collective dedicated efforts of Baishideng staffs, Editorial Board Members, and Peer Reviewers. Among these 47 Baishideng journals, 7 are included in the Science Citation Index Expanded (SCIE) and 6 in the Emerging Sources Citation Index (ESCI). With the support of Baishideng authors, company staffs, Editorial Board Members, and Peer Reviewers, the publication work of 2023 is about to be successfully completed. This editorial summarizes the 2023 activities and accomplishments of the 13 SCIE- and ESCI-indexed Baishideng journals, outlines the Baishideng publishing policy changes and additions made this year, and highlights the unique advantages of Baishideng journals.
引用
收藏
页码:9 / 16
页数:9
相关论文
共 50 条